Carli Cédric, Metz Christine N, Al-Abed Yousef, Naccache Paul H, Akoum Ali
Laboratoire d'endocrinologie de la reproduction, Centre de recherche-Hôpital Saint-François d'Assise, Centre Hospitalier Universitaire de Québec, Faculté de médecine, Université Laval, Québec, Canada.
Endocrinology. 2009 Jul;150(7):3128-37. doi: 10.1210/en.2008-1088. Epub 2009 Mar 19.
Cyclooxygenase (COX) is the rate-limiting enzyme in the metabolic conversion of arachidonic acid to prostaglandins (PGs), including prostaglandin E(2) (PGE(2)), a major mediator of inflammation and angiogenesis. Herein, we report that macrophage migration inhibitory factor (MIF), a potent proinflammatory and growth-promoting factor found at elevated concentrations in the peritoneal fluid of women with endometriosis and active endometriosis lesions, acts directly on ectopic endometrial cells to stimulate the synthesis of COX-2, the inducible form of COX, and the release of PGE(2). MIF treatment strongly activated p38 and ERK MAPK, and specific inhibitors of both pathways completely blocked basal and MIF-induced PGE(2) synthesis. Whereas p38 inhibitors negatively affected the stimulated synthesis of COX-2 and that of PGE(2), ERK inhibitors only decreased the production of PGE(2). These findings show for the first time a direct role for MIF in the up-regulation of COX-2 synthesis and PGE(2) secretion in ectopic endometrial cells. They further indicate that whereas p38 and ERK MAPK signaling pathways both play a significant role in the regulation of basal and MIF-induced synthesis of PGE(2) by ectopic endometrial cells, only p38 kinase is involved in the regulation of COX-2 expression in these cells. This suggests that MIF acts at more than one level to stimulate the synthesis of PGE(2) and triggers the coordinate activation of multiple enzymes in the biosynthesis pathway. Our data provide evidence for a novel mechanism by which MIF can induce a proinflammatory phenotype in ectopic endometrial cells, and favor the establishment of endometriosis and its related clinical symptoms.
环氧化酶(COX)是花生四烯酸代谢转化为前列腺素(PGs)过程中的限速酶,前列腺素包括前列腺素E2(PGE2),它是炎症和血管生成的主要介质。在此,我们报告巨噬细胞移动抑制因子(MIF),一种在子宫内膜异位症患者的腹腔液和活跃的子宫内膜异位症病灶中浓度升高的强效促炎和促生长因子,直接作用于异位子宫内膜细胞,刺激COX-2(COX的诱导型)的合成以及PGE2的释放。MIF处理强烈激活p38和ERK丝裂原活化蛋白激酶(MAPK),并且这两条途径的特异性抑制剂完全阻断基础状态和MIF诱导的PGE2合成。虽然p38抑制剂对COX-2的刺激合成以及PGE2的合成产生负面影响,但ERK抑制剂仅降低PGE2的产生。这些发现首次表明MIF在异位子宫内膜细胞中COX-2合成上调和PGE2分泌中具有直接作用。它们进一步表明,虽然p38和ERK MAPK信号通路在异位子宫内膜细胞基础状态和MIF诱导的PGE2合成调节中均发挥重要作用,但只有p38激酶参与这些细胞中COX-2表达的调节。这表明MIF在多个水平发挥作用以刺激PGE2的合成,并触发生物合成途径中多种酶的协同激活。我们的数据为一种新机制提供了证据,通过该机制MIF可在异位子宫内膜细胞中诱导促炎表型,并促进子宫内膜异位症及其相关临床症状的发生。